CLINICAL TRIALS PROFILE FOR FASTIN

All Clinical Trials for FASTIN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00402077 ↗	A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects	Completed	AstraZeneca	Phase 2	2006-11-01	This study will examine the safety, tolerability, and body weight effect of subcutaneous pramlintide alone and in various combinations with the oral antiobesity agents sibutramine or phentermine in overweight and obese subjects.
NCT03030196 ↗	Denosumab and Male Infertility: a RCT	Active, not recruiting	Martin Blomberg Jensen	Phase 2	2017-01-01	To determine the significance of systemic RANKL inhibition for male reproduction, conducting a clinical controlled randomized double blinded intervention study on infertile men, to investigating whether Denosumab (Prolia) can increase semen quality and to investigate what subgroup of infertile men that might benefit from treatment.

Clinical Trial Conditions for FASTIN

Condition Name

Condition Name for FASTIN
Intervention	Trials
Overweight	1
Infertility, Male	1
Obesity	1

Condition MeSH

Condition MeSH for FASTIN
Intervention	Trials
Body Weight	1
Infertility, Male	1
Infertility	1
Overweight	1

Clinical Trial Locations for FASTIN

Trials by Country

Trials by Country for FASTIN
Location	Trials
United States	10
Denmark	1

Trials by US State

Trials by US State for FASTIN
Location	Trials
New York	1
Kentucky	1
Florida	1
California	1
Arizona	1

Clinical Trial Progress for FASTIN

Clinical Trial Phase

Clinical Trial Phase for FASTIN
Clinical Trial Phase	Trials
Phase 2	2

Clinical Trial Status

Clinical Trial Status for FASTIN
Clinical Trial Phase	Trials
Completed	1
Active, not recruiting	1

Clinical Trial Sponsors for FASTIN

Sponsor Name

Sponsor Name for FASTIN
Sponsor	Trials
AstraZeneca	1
Martin Blomberg Jensen	1

Sponsor Type

Sponsor Type for FASTIN
Sponsor	Trials
Industry	1
Other	1